Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Pariente
Edouard Louis

Showing results (221-230 of 364) with videos related to

Pageof 37
Sort By:
Maedica|August 17, 2023
Impact of Dietary Patterns in Inflammatory Bowel Disease Subtypes <i>Versus</i> Healthy Subjects: a Retrospective Cohort StudyCarmen Monica Preda, Doina Istratescu, Maria Nitescu, et al.
Surgical Endoscopy|August 28, 2014
Computed tomography evaluation of high-grade esophageal necrosis after corrosive ingestion to avoid unnecessary esophagectomyMircea Chirica, Matthieu Resche-Rigon, Benjamin Pariente, et al.
Inflammatory Bowel Diseases|August 8, 2018
Impact of Extra-Intestinal Manifestations at Diagnosis on Disease Outcome in Pediatric- and Elderly-Onset Crohn's Disease: A French Population-Based StudyDana Duricova, Hélène Sarter, Guillaume Savoye, et al.
Annals of the Rheumatic Diseases|March 3, 2011
Discovery and biochemical characterisation of four novel biomarkers for osteoarthritisDominique de Seny, Mohammed Sharif, Marianne Fillet, et al.
Frontiers in Microbiology|May 16, 2022
Association Between Human Gut Microbiome and N-Glycan Composition of Total Plasma ProteomeVyacheslav A Petrov, Sodbo Zh Sharapov, Lev Shagam, et al.
Molecular Cancer|August 31, 2013
Cancer risk in immune-mediated inflammatory diseases (IMID)Rudi Beyaert, Laurent Beaugerie, Gert Van Assche, et al.
Nature Communications|April 28, 2026
Faecalibacterium prausnitzii EXL01 for the Maintenance of Steroid-induced Clinical Response or Remission in Patients with Crohn's Disease: a first in human trialPerle Guarino-Vignon, Edouard Louis, Hang-Phuong Pham, et al.
Inflammatory Bowel Diseases|March 30, 2021
Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel DiseasesClaire Liefferinckx, Jérémie Bottieau, Jean-François Toubeau, et al.
Human Molecular Genetics|September 21, 2007
An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseasesVinciane Dideberg, Gudlaug Kristjansdottir, Lili Milani, et al.
The American Journal of Gastroenterology|October 3, 2002
Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's diseaseSeverine Vermeire, Edouard Louis, An Carbonez, et al.
Pageof 37

Showing results (221-230 of 364) with videos related to

Sort By:
Pageof 37
Maedica|August 17, 2023
Impact of Dietary Patterns in Inflammatory Bowel Disease Subtypes <i>Versus</i> Healthy Subjects: a Retrospective Cohort StudyCarmen Monica Preda, Doina Istratescu, Maria Nitescu, et al.
Surgical Endoscopy|August 28, 2014
Computed tomography evaluation of high-grade esophageal necrosis after corrosive ingestion to avoid unnecessary esophagectomyMircea Chirica, Matthieu Resche-Rigon, Benjamin Pariente, et al.
Inflammatory Bowel Diseases|August 8, 2018
Impact of Extra-Intestinal Manifestations at Diagnosis on Disease Outcome in Pediatric- and Elderly-Onset Crohn's Disease: A French Population-Based StudyDana Duricova, Hélène Sarter, Guillaume Savoye, et al.
Annals of the Rheumatic Diseases|March 3, 2011
Discovery and biochemical characterisation of four novel biomarkers for osteoarthritisDominique de Seny, Mohammed Sharif, Marianne Fillet, et al.
Frontiers in Microbiology|May 16, 2022
Association Between Human Gut Microbiome and N-Glycan Composition of Total Plasma ProteomeVyacheslav A Petrov, Sodbo Zh Sharapov, Lev Shagam, et al.
Molecular Cancer|August 31, 2013
Cancer risk in immune-mediated inflammatory diseases (IMID)Rudi Beyaert, Laurent Beaugerie, Gert Van Assche, et al.
Nature Communications|April 28, 2026
Faecalibacterium prausnitzii EXL01 for the Maintenance of Steroid-induced Clinical Response or Remission in Patients with Crohn's Disease: a first in human trialPerle Guarino-Vignon, Edouard Louis, Hang-Phuong Pham, et al.
Inflammatory Bowel Diseases|March 30, 2021
Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel DiseasesClaire Liefferinckx, Jérémie Bottieau, Jean-François Toubeau, et al.
Human Molecular Genetics|September 21, 2007
An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseasesVinciane Dideberg, Gudlaug Kristjansdottir, Lili Milani, et al.
The American Journal of Gastroenterology|October 3, 2002
Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's diseaseSeverine Vermeire, Edouard Louis, An Carbonez, et al.
Pageof 37